SCHEMBL19675189

SCHEMBL19675189

CCOC(=O)C1NNc2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
MAPT P10636 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
KDM4E B2RXH2 2/20 0.45
TSHR P16473 3/20 0.42
CYP1A2 P05177 3/20 0.40
CYP2C19 P33261 2/20 0.40
MEN1 O00255 1/20 0.39
CYP2D6 P10635 1/20 0.39
KMT2A Q03164 1/20 0.39
IDO1 P14902 1/20 0.38
TDO2 P48775 1/20 0.38
CACNA1C Q13936 2/20 0.38
POLB P06746 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4789768 0.85 TSHR (0.45) ALDH1A1L3MBTL1KDM4ETSHRMEN1
SCHEMBL15597452 0.76 MAPT (0.36) ALDH1A1MAPTL3MBTL1KDM4EMEN1
SCHEMBL3588372 0.74 ALDH1A1 (0.42) ALDH1A1MAPTTSHRMEN1KMT2A
SCHEMBL27619302 0.74 ALDH1A1 (0.62) ALDH1A1MAPTL3MBTL1KDM4ETSHR
SCHEMBL6674552 0.73 ATM (0.39) ALDH1A1MAPTL3MBTL1TSHRCYP2C19
SCHEMBL12185431 0.71 CYP1A2 (0.62) ALDH1A1MAPTL3MBTL1KDM4ETSHR
SCHEMBL29282055 0.71 SLC18A2 (0.43) MAPTKDM4ETSHRCYP1A2CYP2C19
SCHEMBL550205 0.71 KCNH2 (0.47) ALDH1A1MAPTL3MBTL1KDM4ETSHR
SCHEMBL9936784 0.71 CYP1A2 (0.53) ALDH1A1MAPTL3MBTL1KDM4ETSHR
SCHEMBL7218237 0.71 MAPT (0.74) ALDH1A1MAPTL3MBTL1KDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3252050-A1 PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS Bristol-Myers Squibb Company (US) 2017-12-06 EP disclosed
EP-3252049-A1 PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS Bristol-Myers Squibb Company (US) 2017-12-06 EP disclosed